SG11202013235YA - Cannabinoid composition and method for treating ptsd and/or anxiety - Google Patents
Cannabinoid composition and method for treating ptsd and/or anxietyInfo
- Publication number
- SG11202013235YA SG11202013235YA SG11202013235YA SG11202013235YA SG11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA SG 11202013235Y A SG11202013235Y A SG 11202013235YA
- Authority
- SG
- Singapore
- Prior art keywords
- anxiety
- cannabinoid composition
- treating ptsd
- ptsd
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018100925A AU2018100925A4 (en) | 2018-07-03 | 2018-07-03 | Cannabinoid composition and method for treating PTSD and/or anxiety |
| PCT/AU2019/050698 WO2020006597A1 (en) | 2018-07-03 | 2019-07-03 | Cannabinoid composition and method for treating ptsd and/or anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202013235YA true SG11202013235YA (en) | 2021-01-28 |
Family
ID=63079634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202013235YA SG11202013235YA (en) | 2018-07-03 | 2019-07-03 | Cannabinoid composition and method for treating ptsd and/or anxiety |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210308092A1 (en) |
| EP (1) | EP3817735A4 (en) |
| KR (1) | KR20210071940A (en) |
| AU (2) | AU2018100925A4 (en) |
| BR (1) | BR112020027060A2 (en) |
| CA (1) | CA3104739A1 (en) |
| CL (1) | CL2020003374A1 (en) |
| CO (1) | CO2021001059A2 (en) |
| IL (1) | IL279799A (en) |
| MX (1) | MX2021000024A (en) |
| PE (1) | PE20210974A1 (en) |
| SG (1) | SG11202013235YA (en) |
| WO (1) | WO2020006597A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020168073A1 (en) * | 2019-02-13 | 2020-08-20 | Caras Jim | Composition comprising hydrolyzed collagen and cannabidiol and use thereof |
| CN110433133A (en) * | 2019-08-19 | 2019-11-12 | 中国人民解放军军事科学院军事医学研究院 | The cannabidiol nasal formulations for treating posttraumatic stress disorder |
| US20240358726A1 (en) * | 2021-09-03 | 2024-10-31 | Yale University | Specific therapeutic medical marijuana doses for stress and pain |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2895805A1 (en) * | 2012-12-18 | 2014-06-26 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
| BR122021018502B1 (en) * | 2014-10-21 | 2022-05-03 | United Cannabis Corp | Liquid cannabinoid formulation |
| CA2952335A1 (en) * | 2015-12-19 | 2017-06-19 | Delta 9 Gardening B.V. | Therapeutic delivery formulations and systems comprising cannabinoids and terpenes |
| PT3429580T (en) * | 2016-03-16 | 2025-08-12 | Buzzelet Development And Technologies Ltd | Terpene-enriched cannabinoid composition |
| WO2018222923A1 (en) * | 2017-05-31 | 2018-12-06 | Phytecs, Inc. | Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use |
| WO2019089583A1 (en) * | 2017-10-30 | 2019-05-09 | Endocanna Health, Inc. | Cannabinoid formulations |
-
2018
- 2018-07-03 AU AU2018100925A patent/AU2018100925A4/en not_active Ceased
-
2019
- 2019-07-03 US US17/257,768 patent/US20210308092A1/en not_active Abandoned
- 2019-07-03 AU AU2019297196A patent/AU2019297196A1/en not_active Abandoned
- 2019-07-03 CA CA3104739A patent/CA3104739A1/en active Pending
- 2019-07-03 KR KR1020217002448A patent/KR20210071940A/en not_active Ceased
- 2019-07-03 PE PE2020002273A patent/PE20210974A1/en unknown
- 2019-07-03 BR BR112020027060-1A patent/BR112020027060A2/en not_active Application Discontinuation
- 2019-07-03 EP EP19831248.0A patent/EP3817735A4/en not_active Withdrawn
- 2019-07-03 WO PCT/AU2019/050698 patent/WO2020006597A1/en not_active Ceased
- 2019-07-03 SG SG11202013235YA patent/SG11202013235YA/en unknown
- 2019-07-03 MX MX2021000024A patent/MX2021000024A/en unknown
-
2020
- 2020-12-23 CL CL2020003374A patent/CL2020003374A1/en unknown
- 2020-12-27 IL IL279799A patent/IL279799A/en unknown
-
2021
- 2021-01-29 CO CONC2021/0001059A patent/CO2021001059A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL279799A (en) | 2021-03-01 |
| AU2018100925A4 (en) | 2018-08-09 |
| EP3817735A4 (en) | 2022-03-23 |
| BR112020027060A2 (en) | 2021-03-30 |
| CO2021001059A2 (en) | 2021-06-30 |
| MX2021000024A (en) | 2021-05-27 |
| WO2020006597A1 (en) | 2020-01-09 |
| CA3104739A1 (en) | 2020-01-09 |
| CL2020003374A1 (en) | 2021-08-13 |
| US20210308092A1 (en) | 2021-10-07 |
| EP3817735A1 (en) | 2021-05-12 |
| AU2019297196A1 (en) | 2021-01-28 |
| PE20210974A1 (en) | 2021-05-25 |
| KR20210071940A (en) | 2021-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272627A (en) | Terpene-enriched cannabinoid composition and method of treatment | |
| EP3869985A4 (en) | COMPOSITION AND METHOD FOR TREATING THE LUNGS | |
| SG11202002169TA (en) | Composition and method for treating autism | |
| SG11202002874VA (en) | Method, apparatus, and computer-readable medium for compliance aware tokenization and control of asset value | |
| GB2571431B (en) | Electronic apparatus and method for controlling the same | |
| PT3785682T (en) | Cooling apparatus and cooling method | |
| IL251215A0 (en) | Cannabinoid composition and method for treating pain | |
| ZA202000245B (en) | Method and apparatus for pasteurizing and dehydrating marijuana | |
| SG10201709324XA (en) | Apparatus for treatment of waste gas and method for treating the same | |
| GB201700105D0 (en) | Aftertreatment temperature control apparatus and method | |
| GB201819415D0 (en) | Microfluidic apparatus and method | |
| EP4061993A4 (en) | LAUNDRY TREATMENT APPARATUS AND METHOD FOR CONTROLLING THE LAUNDRY TREATMENT APPARATUS | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| SG10201706291TA (en) | Composition And Method For Treating Skin Conditions | |
| EP3660425C0 (en) | COOLING SYSTEM AND CONTROL METHOD FOR IT | |
| IL267988B1 (en) | Method and apparatus for heating and purifying liquids | |
| SG11202013235YA (en) | Cannabinoid composition and method for treating ptsd and/or anxiety | |
| GB201903038D0 (en) | Ophthalmologic apparatus and method of controlling the same | |
| ZA202005720B (en) | Method for treating asthma or allergic disease | |
| ZA201904853B (en) | Demulsification additive composition, use thereof, and method of demulsification | |
| GB201912645D0 (en) | Electronic apparatus and method for controlling the same | |
| IL281151A (en) | Hardening method and apparatus, particularly applicable to metal and/or ceramics | |
| GB201815262D0 (en) | Composition and method | |
| EP3862709C0 (en) | REFRIGERATOR AND METHOD FOR CONTROLLING THE SAME | |
| HUE068710T2 (en) | Nk1-antagonist combination and method for treating synucleinopathies |